Evidence map›Paper›PMID 28185940›Full record

ArticleNanomedicine : nanotechnology, biology, and medicine2017

Twisting electrospun nanofiber fine strips into functional sutures for sustained co-delivery of gentamicin and silver.

Shixuan Chen, Liangpeng Ge, Aubrey Mueller, Mark A Carlson, Matthew J Teusink, Franklin D Shuler, Jingwei Xie

Abstract read
In one paragraph

Article in Nanomedicine : nanotechnology, biology, and medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. A review of current advancements for wound healing: Biomaterial applications and medical devices.Journal of biomedical materials research. Part B, Applied biomaterials · 2022
    Review
  4. Review
  5. Review
  6. Nanofiber curvature with Rho GTPase activity increases mouse embryonic fibroblast random migration velocity.Integrative biology : quantitative biosciences from nano to macro · 2021
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Shixuan ChenDepartment of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE, United States.
Liangpeng GeChongqing Academy of Animal Sciences and Key Laboratory of Pig Industry Sciences, Ministry of Agriculture, Chongqing, China.
Aubrey MuellerDepartment of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE, United States.
Mark A CarlsonDepartment of Surgery-General Surgery, University of Nebraska Medical Center, Omaha, NE, United States.
Matthew J TeusinkDepartment of Orthopaedic Surgery and Rehabilitation, University of Nebraska Medical Center, Omaha, NE, United States.
Franklin D ShulerDepartment of Orthopaedic Surgery, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, United States.
Jingwei XieDepartment of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE, United States. Electronic address: jingwei.xie@unmc.edu.
University of Nebraska Medical Center · USChongqing Academy of Animal Science · CNMarshall University · USNebraska Medical Center · US

Funding

Project 9 - Renal Drug Targeting for the Treatment of Lupus NephritisP20GM103480 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BRONICH, TATIANA K · 2012 to 2017
$13.3M
NIGMS NIH HHS P20 GM103480
6 · The paper itself

Abstract

Surgical site infections (SSIs) represent the most common nosocomial infection among surgical patients. In order to prevent SSIs in a sustained manner and lessen side effects, we developed a twisting method for generation of nanofiber-based sutures capable of simultaneous delivery of silver and gentamicin. The prepared sutures are composed of core-sheath nanofibers with gentamicin/pluronic F127 in the core and silver/PCL in the sheath produced by co-axial electrospinning. The diameters of obtained sutures range from ~80 μm to ~1.2 mm. The in vitro release profiles of silver and gentamicin exhibit an initial burst followed by a sustained release over 5 weeks. The co-encapsulated sutures were able to kill bacteria much more effectively than gentamicin or silver alone loaded nanofiber sutures, without showing obvious impact on proliferation and migration of dermal fibroblasts and keratinocytes. The gentamicin and silver co-loaded PCL nanofiber sutures may hold great potential for prevention of SSIs.

Indexed as

Drug Delivery SystemsSuturesAnti-Bacterial AgentsCell LineCross InfectionDrug LiberationGentamicinsHumansMicrobial Sensitivity TestsNanofibersPolyestersPseudomonas aeruginosaSilverSurgical Wound InfectionAnti-Bacterial AgentsGentamicinspolycaprolactonePolyestersSilverAnti-bacterialCo-deliveryElectrospun nanofibersSurgical site infectionsSuture

Identifiers

PMID28185940
PMCPMC5451297
OpenAlexW2587737417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.